References
- Banegas JR, López-García E, Dallongeville J, Guallar E, Halcox JP, Borghi C, Masso-Gonzalez EL, Jimenez FJ, Perk J, Steg PG, et al. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J. 2011;32(17):2143–52. doi:https://doi.org/10.1093/eurheartj/ehr080. Epub 2011/ 04/08. PubMed PMID: 21471134; PubMed Central PMCID: PMCPmc3164103.
- Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, Bahonar A, Chifamba J, Dagenais G, Diaz R, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. Jama. 2013;310(9):959–68. doi:https://doi.org/10.1001/jama.2013.184182. Epub 2013/ 09/05. PubMed PMID: 24002282.
- Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, Alexander L, Estep K, Hassen Abate K, Akinyemiju TF, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. Jama. 2017;317(2):165–82. doi:https://doi.org/10.1001/jama.2016.19043. Epub 2017/ 01/18. PubMed PMID: 28097354.
- Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension (Dallas, Tex: 1979). 2001;37(5):1236–41. doi:https://doi.org/10.1161/01.hyp.37.5.1236. Epub 2001/ 05/23. PubMed PMID: 11358934.
- Sethi S, Rivera O, Oliveros R, Chilton R. Aortic stiffness: pathophysiology, clinical implications, and approach to treatment. Integr Blood Press Control. 2014;7:29–34. doi:https://doi.org/10.2147/ibpc.s59535. Epub 2014/ 06/10. PubMed PMID: 24910511; PubMed Central PMCID: PMCPmc4046515.
- Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation. 2003;107(22):2864–69. doi:https://doi.org/10.1161/01.cir.0000069826.36125.b4. Epub 2003/ 06/11. PubMed PMID: 12796414.
- Rodríguez-Iturbe B, Pons H, Quiroz Y, Lanaspa MA, Johnson RJ. Autoimmunity in the pathogenesis of hypertension. Nat Rev Nephrol. 2014;10(1):56–62. doi:https://doi.org/10.1038/nrneph.2013.248. Epub 2013/ 11/20. PubMed PMID: 24247285.
- Caillon A, Schiffrin EL. Role of inflammation and immunity in hypertension: recent epidemiological, laboratory, and clinical evidence. Curr Hypertens Rep. 2016;18(3):21. doi:https://doi.org/10.1007/s11906-016-0628-7. Epub 2016/ 02/06. PubMed PMID: 26846785.
- Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754. doi:https://doi.org/10.3389/fimmu.2018.00754. Epub 2018/ 05/01. PubMed PMID: 29706967; PubMed Central PMCID: PMCPmc5908901.
- Hage FG. 2014. C-reactive protein and hypertension. J Hum Hypertens. 28(7):410–15. doi:https://doi.org/10.1038/jhh.2013.111.
- Arques S. Human serum albumin in cardiovascular diseases. Eur J Intern Med. 2018;52:8–12. doi:https://doi.org/10.1016/j.ejim.2018.04.014. Epub 2018/ 04/24. PubMed PMID: 29680174.
- Karabağ Y, Çağdaş M, Rencuzogullari I, Karakoyun S, Artaç I, İliş D, Atalay E, Yesin M, Gürsoy MO, Halil Tanboğa I, et al. Relationship between C-reactive protein/albumin ratio and coronary artery disease severity in patients with stable angina pectoris. J Clin Lab Anal. 2018;32(7):e22457. doi:https://doi.org/10.1002/jcla.22457. Epub 2018/ 04/19. PubMed PMID: 29667724; PubMed Central PMCID: PMCPmc6816976.
- Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, De Simone G, Dominiczak A, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104. doi:https://doi.org/10.1093/eurheartj/ehy339. Epub 2018/ 08/31. PubMed PMID: 30165516.
- Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soci Echocardiography. 2005;18(12):1440–63. doi:https://doi.org/10.1016/j.echo.2005.10.005. Epub 2005/ 12/27. PubMed PMID: 16376782.
- Stratos C, Stefanadis C, Kallikazaros I, Boudoulas H, Toutouzas P. Ascending aorta distensibility abnormalities in hypertensive patients and response to nifedipine administration. Am J Med. 1992;93(5):505–12. doi:https://doi.org/10.1016/0002-9343(92)90577-x. Epub 1992/ 11/01. PubMed PMID: 1442852.
- Tomiyama H, Shiina K, Matsumoto-Nakano C, Ninomiya T, Komatsu S, Kimura K, Chikamori T, Yamashina A, et al. The contribution of inflammation to the development of hypertension mediated by increased arterial stiffness. J Am Heart Assoc. 2017; PubMed PMID: 28666991; PubMed Central PMCID: PMC5586296. 6(7). doi:https://doi.org/10.1161/JAHA.117.005729.
- Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertension. Jama. 2003;290(22):2945–51. doi:https://doi.org/10.1001/jama.290.22.2945. PubMed PMID: 14665655.
- Kullo IJ, Seward JB, Bailey KR, Bielak LF, Grossardt BR, Sheedy PF 2nd, Peyser P, Turner S. C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community. Am J Hypertens. 2005;18(8):1123–29. doi:https://doi.org/10.1016/j.amjhyper.2005.03.730. PubMed PMID: 16109328.
- Maarek B, Simon AC, Levenson J, Pithois-Merli I, Bouthier J. Heterogeneity of the atherosclerotic process in systemic hypertension poorly controlled by drug treatment. Am J Cardiol. 1987;59(5):414–17. doi:https://doi.org/10.1016/0002-9149(87)90947-7[pii]. Epub 1987/ 02/15. PubMed PMID: 3544795.
- Boutouyrie P, Bussy C, Lacolley P, Girerd X, Laloux B, Laurent S. Association between local pulse pressure, mean blood pressure, and large-artery remodeling. Circulation. 1999; 100(13):1387–93. doi:https://doi.org/10.1161/01.CIR.100.13.1387. Epub 1999/ 09/29. PubMed PMID: 10500038.
- Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002;39(1):10–15. doi:https://doi.org/10.1161/hy0102.099031. Epub 2002/ 01/19. PubMed PMID: 11799071.
- Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999; 99(18):2434–39. doi:https://doi.org/10.1161/01.CIR.99.18.2434. Epub 1999/ 05/11. PubMed PMID: 10318666.
- Dogan M, Turak O, Akyel A, Grbovic E, Mendi MA, Oksuz F, Doğan A, Cimen T, Bilgin M, Sunman H, et al. Increased epicardial adipose tissue thickness is linked to aortic stiffness in patients with primary hypertension. Blood Press. 2013. doi:https://doi.org/10.3109/08037051.2013.863991. Epub 2013/ 12/18. PubMed PMID: 24328851.
- Blankenhorn DH, Kramsch DM. Reversal of atherosis and sclerosis. The two components of atherosclerosis. Circulation. 1989; 79(1):1–7. doi:https://doi.org/10.1161/01.CIR.79.1.1. Epub 1989/ 01/01. PubMed PMID: 2642753.
- Frohlich ED. Target organ involvement in hypertension: a realistic promise of prevention and reversal. Med Clin North Am. 2004; 88(1):209–21. doi:https://doi.org/10.1016/S0025-7125(03)00117-2. Epub 2004/ 02/12. PubMed PMID: 14871060.
- Knorr M, Munzel T, Wenzel P. Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction. Front Physiol. 2014;5:295. doi:https://doi.org/10.3389/fphys.2014.00295. Epub 2014/ 09/02. PubMed PMID: 25177297; PubMed Central PMCID: PMC4132269.
- Duffield JS. Macrophages and immunologic inflammation of the kidney. Semin Nephrol. 2010;30(3):234–54. doi:https://doi.org/10.1016/j.semnephrol.2010.03.003. Epub 2010/ 07/14. PubMed PMID: 20620669; PubMed Central PMCID: PMC2922007.
- Katschke KJ Jr., Rottman JB, Ruth JH, Qin S, Wu L, LaRosa G, Ponath P, Park CC, Pope RM, Koch AE, et al. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum. 2001;44(5):1022–32. doi:https://doi.org/10.1002/1529-0131(200105)44:5<1022::AID-ANR181>3.0.CO;2-N. Epub 2001/ 05/16. PubMed PMID: 11352233.
- Mauno V, Hannu K, Esko K. Proinflammation and hypertension: a population-based study. Mediators Inflamm. 2008;2008:619704. doi:https://doi.org/10.1155/2008/619704. Epub 2009/ 01/07. PubMed PMID: 19125204; PubMed Central PMCID: PMC2612739.
- Barhoumi T, Kasal DA, Li MW, Shbat L, Laurant P, Neves MF, Paradis P, Schiffrin EL. T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension. 2011;57(3):469–76. doi:https://doi.org/10.1161/HYPERTENSIONAHA.110.162941. Epub 2011/ 01/26. PubMed PMID: 21263125.
- Takahashi H, Nishimura M, Sakamoto M, Ikegaki I, Nakanishi T, Yoshimura M. Effects of interleukin-1 on blood pressure, sympathetic nerve activity, and pituitary endocrine functions in anesthetized rats. Am J Hypertens. 1992; 5(4 Pt 1):224–29. doi:https://doi.org/10.1093/ajh/5.4.224. Epub 1992/ 04/01. PubMed PMID: 1318054.
- Barbaro NR, Fontana V, Modolo R, De Faria AP, Sabbatini AR, Fonseca FH, Anhê GF, Moreno H. Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers. Blood Press. 2014;1–7. doi:https://doi.org/10.3109/08037051.2014.940710. Epub 2014/ 07/26. PubMed PMID: 25061978.
- Rehman A, Ismail SB, Naing L, Roshan TM, Rahman AR. Reduction in arterial stiffness with angiotensin II antagonism and converting enzyme inhibition. A comparative study among malay hypertensive subjects with a known genetic profile. Am J Hypertens. 2007;20(2):184–89. doi:https://doi.org/10.1016/j.amjhyper.2006.07.015. Epub 2007/ 01/31. PubMed PMID: 17261465.
- Vlachopoulos C, Dima I, Aznaouridis K, Vasiliadou C, Ioakeimidis N, Aggeli C, Toutouza M, Stefanadis C. Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation. 2005;112(14):2193–200. doi:https://doi.org/10.1161/CIRCULATIONAHA.105.535435. Epub 2005/ 09/28. PubMed PMID: 16186422.
- Mukai H, Villafuerte H, Qureshi AR, Lindholm B, Stenvinkel P. Serum albumin, inflammation, and nutrition in end-stage renal disease: c-reactive protein is needed for optimal assessment. Semin Dial. 2018;31(5):435–39. doi:https://doi.org/10.1111/sdi.12731. PubMed PMID: 29926516.
- Mikhailidis DP, Ganotakis ES. Plasma albumin and platelet function: relevance to atherogenesis and thrombosis. Platelets. 1996;7(3):125–37. doi:https://doi.org/10.3109/09537109609023571. PubMed PMID: 21043591.
- Wang W, Ren D, Wang CS, Li T, Yao HC, Ma SJ. Prognostic efficacy of high-sensitivity C-reactive protein to albumin ratio in patients with acute coronary syndrome. Biomark Med. 2019;13(10):811–20. doi:https://doi.org/10.2217/bmm-2018-0346. PubMed PMID: 31144514.
- Cagdas M, Rencuzogullari I, Karakoyun S, Karabag Y, Yesin M, Artac I, Iliş D, Çağdaş ÖS, Tezcan AH, Tanboğa HI, et al. Assessment of relationship between C-reactive protein to albumin ratio and coronary artery disease severity in patients with acute coronary syndrome. Angiology. 2019;70(4):361–68. doi:https://doi.org/10.1177/0003319717743325. PubMed PMID: 29172653.
- Rencuzogullari I, Karabag Y, Cagdas M, Karakoyun S, Seyis S, Gursoy MO, Yesin M, Artac I, İliş D, Tanboğa İH. Assessment of the relationship between preprocedural C-reactive protein/albumin ratio and stent restenosis in patients with ST-segment elevation myocardial infarction. Revista Portuguesa De Cardiologia: Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology: An Official Journal of the Portuguese Society of Cardiology. 2019;38(4):269–77. doi:https://doi.org/10.1016/j.repc.2018.08.008. PubMed PMID: 31104927.
- Yayla C, Gayretli Yayla K. C-reactive protein to albumin ratio in patients with saphenous vein graft disease. Angiology. 2021;3319721998863. doi:https://doi.org/10.1177/0003319721998863. PubMed PMID: 33678042.